FDA
approval
· 2017-04-21
FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
Summary
FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc. The action updates TRUV…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)